P

ProKidney Corp
D

PROK

2.98000
USD
-0.07
(-2.13%)
مغلق
حجم التداول
27,063
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
402,280,719
الأخبار المقالات

العنوان: ProKidney Corp

القطاع: Healthcare
الصناعة: Biotechnology
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment.Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.